The Drake Institute of Behavioral Medicine is a world renowned ADHD and Autism treatment center with over 35 years of clinical experience providing non-drug treatments for the following neurophysical disorders:
The Drake Institute is a world-class ADHD treatment center founded in 1980. We are a pioneer in treating ADHD without medication, and we’ve helped thousands of patients reduce their ADHD symptoms.
Today, the Drake Institute’s non-medication treatment for ADD continues to significantly improve the quality of life for patients from around the world, with a clinical success rate of approximately 80%.
Our clinical treatment process relies on treating Asperger’s patients with a neuroscience-based technology called neurofeedback treatment.
The Drake Institute of Behavioral Medicine provides treatment for anxiety disorder and anxiety-related disorders, such as Generalized Anxiety Disorder, Panic Disorder, Post-Traumatic Stress Disorder, Social Anxiety Disorder, Phobias and Obsessive Compulsive Disorder.
The Drake Institute has successfully treated Autism spectrum disorders and other conditions with a biofeedback and neurofeedback-centered non-drug treatment program.
Anxiety and depression often run together, but one may be more predominant than the other. If you suffer with depression, you are more susceptible to anxiety, and vice versa.
As a medical clinic we offer the distinct advantage of approaching the treatment process with a more comprehensive level of knowledge. We utilize the disciplines of medicine, psychology, neuropsychology, family therapy, neurosciences and computer sciences to offer highly effective ADHD and autism treatment without medication.
If you or a family member need help, please fill out our confidential online form. After completing the form, someone from our Clinical Team will contact you in the next 3 hours.
Founded in 1980 the Drake Institute has successfully treated over 10,000 patients without medication and its unwanted side effects. Utilizing non-drug medical treatment protocols, our record of clinical successes has far exceeded the performance of previous therapies. Approximately 80% of all our patients achieve significant clinical improvement. About 30% of our patients come to us already on medication; in many cases we’re able to reduce or eliminate reliance on medications within 2-4 months, with sustained clinical improvement.
Non-invasive QEEG Brain Mapping is analogous to a physician performing a throat culture on a patient with a throat infection to determine which antibiotic would best eradicate the infection. Brain Mapping gives answers to what’s going on below the surface. The Brain Map analysis gives us important information to more effectively help improve the quality of life and productivity of each individual patient. QEEG (Quantitative Electro- encephalogram) or Brain Mapping is an essential diagnostic procedure for developing non-drug treatment protocols for ADD / ADHD, Autism, Learning Disorders, Anxiety, Substance Abuse, Depression and Stress Related Illnesses.
Brain Mapping data guides our development of neurofeedback treatment protocols which will enable the patient to strengthen and improve brain functioning, reducing their unwanted symptoms. We have used this technology for over 35 years because we know clinically it produces the best long term results for many disorders. Neurofeedback is safe and can lead to long term improvement, unlike the drugs, because neurofeedback uses a learning process that strengthens and develops the synaptic connections in the brain.
Dr. David Velkoff of The Drake Institute on the Dr. Laura Show Copyright 2011, Take On The Day, LLC. Audio interview used by permission.
For over 35 years the Drake Institute has made neurofeedback and biofeedback the centerpiece of its treatment programs. It gives us a method to access brain functioning without any negative side effects and restore normalcy, thereby reducing or eliminating symptoms. It is not an “add-on” to other therapies or medications in the Institute’s treatment programs. . It is the central treatment though we may provide adjunctive counseling or treatment of learning disorders secondarily. Because it has been the central treatment for our patients for 30 years, it has enabled the Drake Institute to develop leading edge knowledge and clinical experience in its applications for ADHD, Autism Spectrum Disorders, and stress related disorders or diseases. All of these disorders have one thing in common : at their core is irregular brain function.
“David F. Velkoff, M.D., our Medical Director and co-founder, supervises all evaluation procedures and treatment programs. He is recognized as a physician pioneer in using biofeedback, qEEG brain mapping, neurofeedback, and neuromodulation in the treatment of ADHD, Autism Spectrum Disorders, and stress related illnesses including anxiety, depression, insomnia, and high blood pressure. Dr. David Velkoff earned his Master’s degree in Psychology from the California State University at Los Angeles in 1975, and his Doctor of Medicine degree from Emory University School of Medicine in Atlanta in 1976. This was followed by Dr. Velkoff completing his internship in Obstetrics and Gynecology with an elective in Neurology at the University of California Medical Center in Irvine. He then shifted his specialty to Behavioral Medicine and received his initial training in biofeedback/neurofeedback in Behavioral Medicine from the leading doctors in the world in biofeedback at the renown Menninger Clinic in Topeka, Kansas. In 1980, he co-founded the Drake Institute of Behavioral Medicine. Seeking to better understand the link between illness and the mind, Dr. Velkoff served as the clinical director of an international research study on psychoneuroimmunology with the UCLA School of Medicine, Department of Microbiology and Immunology, and the Pasteur Institute in Paris. This was a follow-up study to an earlier clinical collaborative effort with UCLA School of Medicine demonstrating how the Drake Institute's stress treatment resulted in improved immune functioning of natural killer cell activity. Dr. Velkoff served as one of the founding associate editors of the scientific publication, Journal of Neurotherapy. He has been an invited guest lecturer at Los Angeles Children's Hospital, UCLA, Cedars Sinai Medical Center-Thalians Mental Health Center, St. John's Hospital in Santa Monica, California, and CHADD. He has been a medical consultant in Behavioral Medicine to CNN, National Geographic Channel, Discovery Channel, Univision, and PBS.”